TSL (Tissue Science Laboratories) set to strengthen Euro side with new agreements
This article was originally published in Clinica
Executive Summary
AIM-quoted UK company Tissue Science Laboratories will build up its European activities with new distribution agreements in key potential markets in the coming months. The company, which specialises in porcine dermis products for the replacement and repair of human tissue, saw its European sales (including UK) more than double to around £1bn ($1.56bn) in 2002, in a year described by CEO Martin Hunt as one of "good progress".